Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
LRP2 is a potential molecular target for nonsyndromic pathological myopia
Kimberley Delaunay, Emilie Picard, Patricia Lassiaz, Laurent Jonet, Vidjea Cannaya, José Maria Ruiz-Moreno, Kentaro Kojima, Henrik Vorum, Bent Honoré, Jorge Ruiz-Medrano, Lasse Jørgensen Cehofski, Eric Pussard, Renata Kozyraki, Alicia Torriglia, Olivier Cases, Francine Behar-Cohen
Kimberley Delaunay, Emilie Picard, Patricia Lassiaz, Laurent Jonet, Vidjea Cannaya, José Maria Ruiz-Moreno, Kentaro Kojima, Henrik Vorum, Bent Honoré, Jorge Ruiz-Medrano, Lasse Jørgensen Cehofski, Eric Pussard, Renata Kozyraki, Alicia Torriglia, Olivier Cases, Francine Behar-Cohen
View: Text | PDF
Research Article Neuroscience Ophthalmology

LRP2 is a potential molecular target for nonsyndromic pathological myopia

  • Text
  • PDF
Abstract

High myopia (HM) and posterior staphyloma (PS) are major causes of vision loss worldwide. Genetic and environmental factors, especially light exposure, influence myopia. This study shows that low-density lipoprotein–related receptor type 2 (LRP2) levels are decreased in the vitreous of patients with HM and PS, and that in human donor eyes affected by PS, LRP2 expression was reduced in the neural retina and retinal pigment epithelium (RPE), with morphologic changes similar to those observed in the Foxg1-Cre-Lrp2fl/fl mouse that also develops PS. In human induced pluripotent stem cell–derived RPE cells, LRP2 silencing regulated genes involved in eye and neuronal development, visual perception, tissue remodeling, hormone metabolism, and RPE structure. Its expression increased under light exposure, particularly red light, but was downregulated by cortisol. These findings establish a link between LRP2, myopization, and environmental factors, highlighting its crucial role in nonsyndromic HM and PS. LRP2 appears to be a promising therapeutic target for HM treatment.

Authors

Kimberley Delaunay, Emilie Picard, Patricia Lassiaz, Laurent Jonet, Vidjea Cannaya, José Maria Ruiz-Moreno, Kentaro Kojima, Henrik Vorum, Bent Honoré, Jorge Ruiz-Medrano, Lasse Jørgensen Cehofski, Eric Pussard, Renata Kozyraki, Alicia Torriglia, Olivier Cases, Francine Behar-Cohen

×

Figure 5

Organization of the RPE is altered in HM eye, similar to the RPE in Lrp2-cKO mice.

Options: View larger image (or click on image) Download as PowerPoint
Organization of the RPE is altered in HM eye, similar to the RPE in Lrp2...
(A) Phalloidin staining reveals the geometric paving pattern of RPE in the emmetropic eye. (B–D) In HM eye, RPE geometric paving pattern is lost as most cells increase in size. Bicellular junctions display secondary actin arcs (C, arrows) and cell junctions are disorganized (D arrows). (E and F) Phalloidin staining on RPE flat mount of WT control mouse shows the regular pattern of RPE cells. (G) Zonula occludens 1 (ZO-1) follows the distribution of phalloidin in the apical pole. (H and I) In Lrp2-cKO RPE, the pseudogeometric paving pattern is lost and is replaced by a tangle of cells whose surface has increased. (J) ZO-1 is redistributed in the cytoplasm of abnormally shaped RPE cells. (K) Digital overlay reconstruction of control and Lrp2-cKO RPE indicates the increase size in cells both at the periphery and at the intermediate level of the retina in Lrp2-cKO RPE. (L) Cell area in μm2, (M) cell density in number of cells/mm2, and (N) distribution of cells by sizes in the intermediate and peripheral retina of control compared to Lrp2-cKO mice. Values represent the mean of cell size average of each sample (n = 7) per genotype ± SEM. Mann-Whitney U test. ***P < 0.001. Scale bars: 50 μm (A–D, E, and H), 25 μm (F and I), and 75 μm (G and J).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts